Back
Product details:
CAS
2809-21-4
Purity
95%
Etidronate is a non-aminobisphosphonate. It shows protein tyrosine phosphatase inhibitory activity. Etidronate is indicated to treat Paget's disease of bone, as well as the treatment and prevention of heterotropic ossification after total hip replacement of spinal cord injury.
Properties
Name
Etidronate
Smiles
CC(O)(P(=O)(O)O)P(=O)(O)O
Targets
Please log in to see this information
SDS
1-Hydroxyethane-1,1-diphosphonic acid | 1-hydroxyethylene-(1,1-diphosphonic acid) | 1-hydroxyethylidene-1,1-diphosphonic acid | 1-hydroxyethylidenediphosphonic acid | HEDP | etidronate | etidronic acid | hydroxyethylidenediphosphonic acid
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$45
2 mg
$47
5 mg
$48
10 mg
$49
15 mg
$50
20 mg
$51
25 mg
$55
30 mg
$59
35 mg
$67
40 mg
$74
45 mg
$81
50 mg
$88
75 mg
$94
100 mg
$96
Quantity
1
Total amount
$ 48
1-Hydroxyethane-1,1-diphosphonic acid | 1-hydroxyethylene-(1,1-diphosphonic acid) | 1-hydroxyethylidene-1,1-diphosphonic acid | 1-hydroxyethylidenediphosphonic acid | HEDP | etidronate | etidronic acid | hydroxyethylidenediphosphonic acid
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.